Prevalence and associated factors of complementary and integrative medicine use in patients afflicted with COVID-19

Parvizi, MM; Forouhari, S; Shahriarirad, R; Shahriarirad, S; Bradley, RD; Roosta, L

Prevalence and associated factors of complementary and integrative medicine use in patients afflicted with COVID-19

Parvizi, MM Forouhari, S Shahriarirad, R Shahriarirad, S Bradley, RD Roosta, L

Permalink

Publisher:: Springer Nature
Publication Type:: Journal Article
Citation:: BMC Complement Med Ther, 2022, 22, (1), pp. 251
Issue Date:: 2022-09-30

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Adobe PDF

Download Published versionAdobe PDF (1.1 MB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Parvizi, MM
dc.contributor.author	Forouhari, S
dc.contributor.author	Shahriarirad, R
dc.contributor.author	Shahriarirad, S
dc.contributor.author	Bradley, RD
dc.contributor.author	Roosta, L
dc.date.accessioned	2023-04-12T21:14:59Z
dc.date.available	2022-09-12
dc.date.available	2023-04-12T21:14:59Z
dc.date.issued	2022-09-30
dc.identifier.citation	BMC Complement Med Ther, 2022, 22, (1), pp. 251
dc.identifier.issn	1472-6882
dc.identifier.issn	2662-7671
dc.identifier.uri	http://hdl.handle.net/10453/169657
dc.description.abstract	BackgroundComplementary and Integrative Medicine (CIM) is often taken up by individuals seeking relief from different diseases. This study investigates the prevalence and associated factors of CIM use in patients with COVID-19.MethodsIn this telephone-based, cross-sectional study, data on CIM usage were collected from COVID-19 patients from February till June 2020 in Fars province, Iran using a researcher-made checklist. Additionally, we asked about the patients’ attitudes toward these treatments.ResultsOut of 453 patients diagnosed with COVID-19, 400 (88.30%) responded to our calls and agreed to participate in the study. Among them, 276 patients reported using CIM to treat COVID-19 [prevalence: 69% (95% CI: 64.2 to 73.5)]. The most frequently used herbal medicine among COVID-19 patients was ginger (n = 273, 98.9%), thyme (n = 263, 95.3%), and black cumin (n = 205, 74.3%). Most of these patients were recommended to use herbal medicine by their families and friends (n = 96, 34.8%). Univariable logistic regression revealed that age under 50 years old, residency in urban areas (including the capital of the province and small cities), employment, academic education, and being an outpatient were statistically significant factors resulting in CIM usage. Multivariable logistic regression revealed that CIM use among outpatients was 3.65 times more than among inpatients. In addition, patients under 50 years old used CIM 85% more than older patients. Ultimately, only 9 (3.3%) patients consulted with their doctors regarding these medications. No side effects due to CIM use were reported.ConclusionMany patients with COVID-19 used CIM, but few consulted with their physicians in this regard. Therefore, physicians should ask their patients about CIM usage, and patients should also report their use of CIM therapies during their medical visits. Furthermore, age and hospitalization status affected CIM use among patients with COVID-19.
dc.format	Electronic
dc.language	eng
dc.publisher	Springer Nature
dc.relation.ispartof	BMC Complement Med Ther
dc.relation.isbasedon	10.1186/s12906-022-03722-x
dc.rights	info:eu-repo/semantics/openAccess
dc.subject	1104 Complementary and Alternative Medicine
dc.subject.classification	Complementary & Alternative Medicine
dc.subject.mesh	COVID-19
dc.subject.mesh	Complementary Therapies
dc.subject.mesh	Cross-Sectional Studies
dc.subject.mesh	Humans
dc.subject.mesh	Integrative Medicine
dc.subject.mesh	Middle Aged
dc.subject.mesh	Prevalence
dc.subject.mesh	Humans
dc.subject.mesh	Complementary Therapies
dc.subject.mesh	Prevalence
dc.subject.mesh	Cross-Sectional Studies
dc.subject.mesh	Middle Aged
dc.subject.mesh	Integrative Medicine
dc.subject.mesh	COVID-19
dc.subject.mesh	COVID-19
dc.subject.mesh	Complementary Therapies
dc.subject.mesh	Cross-Sectional Studies
dc.subject.mesh	Humans
dc.subject.mesh	Integrative Medicine
dc.subject.mesh	Middle Aged
dc.subject.mesh	Prevalence
dc.title	Prevalence and associated factors of complementary and integrative medicine use in patients afflicted with COVID-19
dc.type	Journal Article
utslib.citation.volume	22
utslib.location.activity	England
utslib.for	1104 Complementary and Alternative Medicine
utslib.copyright.status	open_access	*
dc.date.updated	2023-04-12T21:14:54Z
pubs.issue	1
pubs.publication-status	Published online
pubs.volume	22
utslib.citation.issue	1

Abstract:

BackgroundComplementary and Integrative Medicine (CIM) is often taken up by individuals seeking relief from different diseases. This study investigates the prevalence and associated factors of CIM use in patients with COVID-19.MethodsIn this telephone-based, cross-sectional study, data on CIM usage were collected from COVID-19 patients from February till June 2020 in Fars province, Iran using a researcher-made checklist. Additionally, we asked about the patients’ attitudes toward these treatments.ResultsOut of 453 patients diagnosed with COVID-19, 400 (88.30%) responded to our calls and agreed to participate in the study. Among them, 276 patients reported using CIM to treat COVID-19 [prevalence: 69% (95% CI: 64.2 to 73.5)]. The most frequently used herbal medicine among COVID-19 patients was ginger (n = 273, 98.9%), thyme (n = 263, 95.3%), and black cumin (n = 205, 74.3%). Most of these patients were recommended to use herbal medicine by their families and friends (n = 96, 34.8%). Univariable logistic regression revealed that age under 50 years old, residency in urban areas (including the capital of the province and small cities), employment, academic education, and being an outpatient were statistically significant factors resulting in CIM usage. Multivariable logistic regression revealed that CIM use among outpatients was 3.65 times more than among inpatients. In addition, patients under 50 years old used CIM 85% more than older patients. Ultimately, only 9 (3.3%) patients consulted with their doctors regarding these medications. No side effects due to CIM use were reported.ConclusionMany patients with COVID-19 used CIM, but few consulted with their physicians in this regard. Therefore, physicians should ask their patients about CIM usage, and patients should also report their use of CIM therapies during their medical visits. Furthermore, age and hospitalization status affected CIM use among patients with COVID-19.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/169657